Medications

FDA issues multiple sclerosis drug alert

(HealthDay) -- The multiple sclerosis drug Gilenya (fingolimod) should not be given to patients with certain pre-existing or recent heart conditions or stroke, or those taking certain medications to correct heart rhythm problems, ...

Psychology & Psychiatry

Fewer suicides after antidepressive treatment for schizophrenia

(Medical Xpress) -- Antidepressive drugs reduce the mortality rate of schizophrenic patients, while treatment with bensodiazepines greatly increases it, especially as regards suicide. Giving several antipsychotics simultaneously, ...

Cardiology

Blood cell breakthrough could help treat heart disease

(Phys.org) -- Scientists at the University of Reading have made a groundbreaking discovery into the way blood clots are formed, potentially leading to the development of new drugs to treat one of the world's biggest killer ...

Neuroscience

ONO-4641 pill reduced number of MS lesions in Phase II trial

An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented as Emerging Science (formerly known ...

Alzheimer's disease & dementia

Cholesterol drug shows benefit in animal study of Alzheimer's disease

A cholesterol drug commonly prescribed to reduce cardiovascular disease risk restores blood vessel function in a mouse model of Alzheimer's disease, according to a study in the April 4 issue of The Journal of Neuroscience. ...

Medications

Benefits of Varenicline (Chantix) may balance certain risks

(Medical Xpress) -- The U.S. Food and Drug Administration (FDA) has approved the smoking cessation medication varenicline (Chantix) as an effective aide in helping people quit smoking, including those with cardiovascular ...

page 24 from 29